30th August, 2017

BREATH Dumfries & Galloway Stakeholder Event

General News | Outreach News | QUB | UWS

BREATH hosted an evening event to bring together over 30 healthcare workers, scientists, businesses and policy makers to discuss South West Scotland’s progress towards the deadly lung disease, COPD.

The event at the University’s campus in Dumfries – a known COPD ‘hotspot’ – hosted attendees looking to learn more about new research on the lung disease which takes over 600,000 lives in the EU every year.

Several key players presented, including: Prof Lorcan McGarvey (QUB), Dr Stuart Little (NHS Ayrshire & Arran), Dr Gary Litherland (UWS), Prof John Lockhart (UWS), and Emma Harper MSP.

Picture are L to R, top to bottom of first 3 rows:  Prof Ehsan Mesbahi (Vice Prinicipal, UWS; via videoconference), Prof Lorcan McGarvey (BREATH Clinical Lead, QUB), Dr Stuart Little (Respiratory Consutant,NHS Dumfries and Galloway), Dr Gary Litherland (BREATH PI, UWS), Prof John Lockhart (BREATH PI, UWS), Emma Harper MSP, Prof Lorraine Martin (BREATH PI, QUB) & Dr Anne Crilly (BREATH PI, UWS), Phyllis Murphy (Respiratory Nurse Consultant, NHS Dumfries and Galloway), British Lung Foundation and Chest Heart & Stroke Scotland representatives,

     

     

     

     

Back to Latest News

More News

30th September, 2020
BREATH Presented at Scottish Parliament CPG on Lung Health

General News Outreach News

Professor John Lockhart and Clinical BREATH Affiliate Phyllis Murphie presented BREATH at the Scottish Parliament’s Cross Party Group on Lung Health 21st September.

Read Article
3rd November, 2023
BREATH Success: UWS PhD student Carly Woods successfully defends thesis at viva

General News UWS

Carly Woods successfully undertook her viva voce examination on the 30th October, defending a doctoral thesis entitled: Particulate Matter and Potential Health Impacts in a Remote Environment.

Read Article
20th July, 2021
Almac Discovery links with BREATH to Expand Disease Focus into Respiratory Disease

QUB Research

Dr James Reihill joins Almac Discovery to further support the exploration of the role of Deubiquitinating enzymes (DUBs) in the development of new drugs for major respiratory diseases including chronic obstructive pulmonary disease (COPD)

Read Article
Archives
  • 2023 (4)
  • 2022 (13)
  • 2021 (16)
  • 2020 (13)
  • 2019 (20)
  • 2018 (9)
  • 2017 (5)
  • Contact
    • +353 (0) 42 9370 447